• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
278.75 -11 (-3.76%)
  • As on 26 Apr 2025 (EOD)

  • Today’s Low

    272.05

  • Today’s High

    292.45

  • Open

    292.45

  • Perv Close

    289.65

  • 52W Low

    145.00

  • 52W High

    449.00

Key Indicators

  • P/E(TTM)

    26.42

  • Mar.Cap (₹Cr.)

    820.39

  • Div & Yield %

    0.44

  • Book Value(₹)

    107.10

  • Debt-Equity Ratio

    -3.76

  • AGM Date

    25-Apr-2025

  • EPS

    10.55

  • P/E Ratio

    26.42

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    820.39

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    107.10

  • Sales( ₹ in Cr.)

    307.09

  • NP (in Cr.)

    -7.74

  • NP Var(%)

    -351.0

  • Div%

    25.0

  • CPS (₹)

    5.40

  • EPS (₹)

    -2.60

  • Traded Value (₹ in Lakhs)

    820.39

  • 52 Week High

    449.00

  • 52 Week Low

    145.00

  • Price BSE

    279.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    820.39

  • P/C Ratio

    51.50

  • P/E Ratio

    -106.10

  • Price Vs.BV

    -2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 307.09 328.91 387.96 372.82 300.51 404.67
Excise Duty 0.00 0.00 0.00 0.00 1.24 1.22
Net Sales 307.09 328.91 387.96 372.82 299.27 403.45
Other Income 8.15 8.46 7.53 6.62 12.31 12.34
Stock Adjustments -13.86 -17.29 -7.65 15.88 20.79 12.82
Total Income 301.38 320.08 387.84 395.32 332.37 428.61
EXPENDITURE :            
Raw Materials 91.57 109.21 136.55 139.52 103.46 105.08
Power and Fuel Cost 19.78 18.24 20.35 14.23 12.74 13.88
Employee Cost 53.93 53.81 59.36 57.50 50.03 53.18
Other Manufacturing Expenses 50.29 44.12 43.65 36.06 27.85 31.07
Selling and Administration Expenses 34.46 38.73 38.16 37.25 47.28 53.13
Miscellaneous Expenses 14.87 68.12 5.42 9.41 8.25 18.01
Employee Benefit Expenses 53.93 53.81 59.36 57.50 50.03 53.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 264.90 332.23 303.50 293.96 249.61 274.35
Operating Profit 36.49 -12.14 84.35 101.36 82.75 154.27
Interest 17.40 21.35 18.11 19.10 20.27 21.30
Gross Profit 19.09 -33.49 66.24 82.26 62.48 132.97
Depreciation 23.70 24.49 23.67 19.03 14.94 11.85
Profit Before Tax -4.61 -57.98 42.57 63.23 47.54 121.12
Current Tax 14.14 -0.97 7.41 11.26 3.37 31.92
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 4.92 0.00 -19.49 -21.15
Reported Net Profit -18.74 -57.00 30.24 51.97 63.67 110.35
Extraordinary Items -11.01 -60.09 -0.02 -0.13 1.90 -4.78
Adjusted Net Profit -7.73 3.09 30.26 52.10 61.77 115.13
Adjustment below Net Profit 0.12 9.52 -0.24 -0.04 -6.22 98.95
P & L Balance brought forward 299.03 350.72 327.93 275.99 218.54 9.24
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.61 4.20 7.21 0.00 0.00 0.00
P & L Balance carried down 276.80 299.03 350.72 327.93 275.99 218.54
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 25.00 25.00 50.00 100.00 25.00
Dividend Per Share(Rs) 1.25 1.25 1.25 2.50 5.00 1.25
Earnings Per Share-Unit Curr -6.49 -19.75 10.48 18.01 22.07 120.30
Earnings Per Share(Adj)-Unit Curr -6.49 -19.75 10.48 18.01 22.07 40.10
Book Value 108.83 116.45 137.26 128.42 108.36 271.74
Book Value(Adj)-Unit Curr 108.83 116.45 137.26 128.42 108.36 90.58

Shareholding Pattern

  • Promoter Group

    64.09%

  • Public Share Holding

    35.02%

  • Custodian

    0.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 2,240,376 2,240,376.00 2,240,376 2,240,376
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,240,376 7.61 2,240,376 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,620,633 56.47 16,620,633 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,620,633 56.47 16,620,633 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,298 0.02 7,298 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,418 0.03 7,418 3
2] Non Institution
Bodies Corporate 567,630 1.93 567,030 107
Clearing Members 1,000 0.00 1,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 273,641 0.93 273,641 308
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 263,745 0.90 263,745 387
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,329,312 11.31 3,329,312 24
Individuals holding nominal share capital up to Rs. 1 lakh 5,612,790 19.07 5,393,467 12,079
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 46,800 0.16 46,800 1
Others 172,926 0.59 172,926 1
Sub Total 10,300,549 35.00 10,080,626 12,922
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 262,011 0.89 262,011 1
Total Shares held by Custodians and against which Depository Receipts have been issued 262,011 0.89 262,011 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,211,064 12,930

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

    Srikant N Sharma

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Novartis India 818.35 396.75 335.07 23.42 15.57
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92